Latest News

Potential harms of state PDABs on HIV treatment access and ending the epidemic.

Unintended consequences of Inflation Reduction Act drug pricing provisions.

Stigma, discrimination, and resilience in LGBTQIA+ communities' fight for health equity.

Analysis of ADA protections for PLWHA including workplace discrimination and HIV criminalization.

HHS proposed viral hepatitis quality measures for Medicaid and health equity implications.

Declining HCV infections but persistent treatment barriers and disparities remain.

Copay accumulator schemes and Essential Health Benefits loophole; Louisiana as model.

WHO updated hepatitis B guidelines: implications for global HBV testing and treatment.

How payor cost-containment strategies drive health disparities and limit care access.

Systemic discrimination against transgender people in healthcare and society.

Rising medical debt burden among insured Americans and systemic causes.

2024 federal healthcare policy priorities: 340B reform, PBM oversight, and telehealth.

CANN outlines organizational growth and 2024 policy priorities including state-level advocacy.

Proposed $767M HIV cuts betray bipartisan legacy; RWHAP and PEPFAR face critical funding threats.

World AIDS Day 35th anniversary: centering PLWH voices and investing in lived-experience leadership.

HCV vaccine development requires addressing immune variability, access barriers, and community trust.

PDABs and upper-payment limits risk restricting medication access despite affordability intentions.

$100 billion 340B program lacks patient accountability; reform needed for charitable care obligations.

CMS's $9B remedy to hospitals after SCOTUS 340B ruling lacks enforcement of charitable care requirements.

Payers face regulatory scrutiny for systematic coverage denials and prior authorization abuse.